Breyanzi
E1585352
UNEXPLORED
Breyanzi is a CD19-directed CAR T-cell therapy used to treat certain types of relapsed or refractory large B-cell lymphoma.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Breyanzi canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T23417460 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Breyanzi Context triple: [Bristol Myers Squibb, product, Breyanzi]
-
A.
Beutler
Beutler is a surname most notably associated with Bruce A. Beutler, an American immunologist and Nobel Prize laureate recognized for his work on innate immunity.
-
B.
Trikafta
Trikafta is a breakthrough combination therapy for cystic fibrosis that targets the underlying genetic defect to improve lung function and reduce symptoms in eligible patients.
-
C.
Ultomiris
Ultomiris is a long-acting monoclonal antibody therapy used to treat rare complement-mediated blood disorders such as paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
-
D.
Onpattro
Onpattro is an RNA interference (RNAi) therapeutic used to treat polyneuropathy in adults with hereditary transthyretin-mediated (hATTR) amyloidosis.
-
E.
Bantigen
Bantigen is a small locality within the municipality of Bolligen in the canton of Bern, Switzerland.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Breyanzi Target entity description: Breyanzi is a CD19-directed CAR T-cell therapy used to treat certain types of relapsed or refractory large B-cell lymphoma.
-
A.
Beutler
Beutler is a surname most notably associated with Bruce A. Beutler, an American immunologist and Nobel Prize laureate recognized for his work on innate immunity.
-
B.
Trikafta
Trikafta is a breakthrough combination therapy for cystic fibrosis that targets the underlying genetic defect to improve lung function and reduce symptoms in eligible patients.
-
C.
Ultomiris
Ultomiris is a long-acting monoclonal antibody therapy used to treat rare complement-mediated blood disorders such as paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
-
D.
Onpattro
Onpattro is an RNA interference (RNAi) therapeutic used to treat polyneuropathy in adults with hereditary transthyretin-mediated (hATTR) amyloidosis.
-
E.
Bantigen
Bantigen is a small locality within the municipality of Bolligen in the canton of Bern, Switzerland.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.